logo

Cns Pharmaceuticals Inc (CNSP Stock: A Sea of Opportunity

DOYU

Cns Pharmaceuticals Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $23.90 on 03/11/24, while the lowest price for the same period was registered at $0.08 on 01/29/25.

52-week price history of CNSP Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Cns Pharmaceuticals Inc’s current trading price is -99.35% away from its 52-week high, while its distance from the 52-week low is 86.95%. The stock’s price range during the 52-week period has remained between $0.08 and $23.90. In the Healthcare sector, the company’s shares saw a trading volume of around 383.8 million for the day, which was evidently higher than the average daily volume of 16.61 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Cns Pharmaceuticals Inc (CNSP) has experienced a quarterly rise of 22.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.98M and boasts a workforce of 5 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1165, with a change in price of +0.0248. Similarly, Cns Pharmaceuticals Inc recorded 22,190,109 in trading volume during the last 100 days, posting a change of +17.34%.

Examining CNSP’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CNSP stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

CNSP Stock Stochastic Average

Cns Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 79.15%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 79.15%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 63.09% and 58.86%, respectively.

CNSP Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 29.65% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 12.71%. Over the past 30 days, the price of CNSP has fallen by 43.21%. And in the last five days, it has surged by 66.60%.

Most Popular